Response to Sarpal et al.: Importance of Neuroimaging Biomarkers for Treatment Development and Clinical Practice

Affiliations

Comment

Qiyong Gong. Am J Psychiatry. 2016.

. 2016 Jul 1;173(7):733-4.

doi: 10.1176/appi.ajp.2016.16030320r.

¹ From Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China.

No abstract available

Comment on

A Selective Review of Cerebral Abnormalities in Patients With First-Episode Schizophrenia Before and After Treatment.
Gong Q, Lui S, Sweeney JA. Gong Q, et al. Am J Psychiatry. 2016 Mar 1;173(3):232-43. doi: 10.1176/appi.ajp.2015.15050641. Epub 2015 Dec 1. Am J Psychiatry. 2016. PMID: 26621570 Review.
In Support of Neuroimaging Biomarkers of Treatment Response in First-Episode Schizophrenia.
Sarpal DK, Lencz T, Malhotra AK. Sarpal DK, et al. Am J Psychiatry. 2016 Jul 1;173(7):732-3. doi: 10.1176/appi.ajp.2016.16030320. Am J Psychiatry. 2016. PMID: 27363555 Free PMC article. No abstract available.